SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of $160.71 million. The enterprise value is $171.72 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.59 million shares outstanding. The number of shares has increased by 103.51% in one year.
| Current Share Class | 8.59M |
| Shares Outstanding | 8.59M |
| Shares Change (YoY) | +103.51% |
| Shares Change (QoQ) | -3.78% |
| Owned by Insiders (%) | 15.77% |
| Owned by Institutions (%) | 29.04% |
| Float | 5.80M |
Valuation Ratios
The trailing PE ratio is 45.83 and the forward PE ratio is 48.57.
| PE Ratio | 45.83 |
| Forward PE | 48.57 |
| PS Ratio | 3.65 |
| Forward PS | 3.04 |
| PB Ratio | 99.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 83.10 |
| P/OCF Ratio | 41.46 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 22.94, with an EV/FCF ratio of 88.79.
| EV / Earnings | 14.54 |
| EV / Sales | 3.90 |
| EV / EBITDA | 22.94 |
| EV / EBIT | 26.37 |
| EV / FCF | 88.79 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 14.19.
| Current Ratio | 1.38 |
| Quick Ratio | 0.97 |
| Debt / Equity | 14.19 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 11.88 |
| Interest Coverage | 1.04 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.07% |
| Return on Invested Capital (ROIC) | 52.67% |
| Return on Capital Employed (ROCE) | 33.40% |
| Weighted Average Cost of Capital (WACC) | 14.36% |
| Revenue Per Employee | $800,927 |
| Profits Per Employee | $214,782 |
| Employee Count | 55 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, SANUWAVE Health has paid $86,000 in taxes.
| Income Tax | 86,000 |
| Effective Tax Rate | 0.72% |
Stock Price Statistics
The stock price has decreased by -33.98% in the last 52 weeks. The beta is 1.51, so SANUWAVE Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -33.98% |
| 50-Day Moving Average | 20.87 |
| 200-Day Moving Average | 30.19 |
| Relative Strength Index (RSI) | 46.21 |
| Average Volume (20 Days) | 83,134 |
Short Selling Information
The latest short interest is 620,241, so 7.22% of the outstanding shares have been sold short.
| Short Interest | 620,241 |
| Short Previous Month | 593,047 |
| Short % of Shares Out | 7.22% |
| Short % of Float | 10.69% |
| Short Ratio (days to cover) | 7.18 |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of $44.05 million and earned $11.81 million in profits. Earnings per share was $0.41.
| Revenue | 44.05M |
| Gross Profit | 33.97M |
| Operating Income | 6.51M |
| Pretax Income | 11.90M |
| Net Income | 11.81M |
| EBITDA | 7.49M |
| EBIT | 6.51M |
| Earnings Per Share (EPS) | $0.41 |
Full Income StatementBalance Sheet
The company has $11.96 million in cash and $22.97 million in debt, with a net cash position of -$11.01 million or -$1.28 per share.
| Cash & Cash Equivalents | 11.96M |
| Total Debt | 22.97M |
| Net Cash | -11.01M |
| Net Cash Per Share | -$1.28 |
| Equity (Book Value) | 1.62M |
| Book Value Per Share | 0.19 |
| Working Capital | 6.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $3.88 million and capital expenditures -$1.94 million, giving a free cash flow of $1.93 million.
| Operating Cash Flow | 3.88M |
| Capital Expenditures | -1.94M |
| Depreciation & Amortization | 974,000 |
| Net Borrowing | -5.77M |
| Free Cash Flow | 1.93M |
| FCF Per Share | $0.23 |
Full Cash Flow StatementMargins
Gross margin is 77.11%, with operating and profit margins of 14.78% and 26.82%.
| Gross Margin | 77.11% |
| Operating Margin | 14.78% |
| Pretax Margin | 27.01% |
| Profit Margin | 26.82% |
| EBITDA Margin | 16.99% |
| EBIT Margin | 14.78% |
| FCF Margin | 4.39% |
Dividends & Yields
SANUWAVE Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -103.51% |
| Shareholder Yield | -103.51% |
| Earnings Yield | 7.35% |
| FCF Yield | 1.20% |
Analyst Forecast
The average price target for SANUWAVE Health is $51.00, which is 171.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $51.00 |
| Price Target Difference | 171.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on October 18, 2024. It was a reverse split with a ratio of 1:375.
| Last Split Date | Oct 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:375 |
Scores
SANUWAVE Health has an Altman Z-Score of -2.52 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.52 |
| Piotroski F-Score | 6 |
